• Home
  • Return to INGSA Homepage
  • Science Advice in Emergencies
  • Evidence-to-Policy Tracker
  • Outputs and Reports
  • Home
  • Return to INGSA Homepage
  • Science Advice in Emergencies
  • Evidence-to-Policy Tracker
  • Outputs and Reports

Two New Policy Briefs: Developing and Manufacturing Vaccines in Pandemics

by INGSA Secretariat | posted in: COVID Reports, COVID-19 Commentary | 0
For vaccines to form part of a viable epidemic or pandemic recovery strategy, they must be available quickly and be manufacturable at scale. Click on the Policy Briefs to read
Input square image here

Policy Impact Unit

University College London,
STEaPP

@UCLSTEaPP
HOME
Europe, Manufacturing, Post-COVID, Science Systems, STEaPP, UCL, UK, Vaccine

INGSA is a New Zealand-based International Organisation hosted at the University of Auckland by Koi Tū: Centre for Informed Futures
Charity Registration Number: CC58851

INGSA operates under the auspices
of the International Science Council

  • Twitter
  • Flickr
  • YouTube
  • LinkedIn

© 2025 INGSA - Covid - Website by The Design Web - WordPress Theme by Kadence WP - Image credits